Nature's Sunshine Prices Secondary Offering of Fosun Pharma's 2.85 Million Shares; May Buy Back Up to 15 Million

LEHI, Utah, June 26, 2025 --

Nature's Sunshine Products said it priced an underwritten secondary public offering of up to 2,854,607 shares of its common stock being sold by Fosun Pharma USA Inc. at 12.00 dollars per share. The offering was expected to close on June 27, 2025. Fosun will receive all net proceeds, and Nature's Sunshine is not selling any shares.

As part of the offering, the company agreed with Fosun that it may buy up to 15.0 million dollars of the offered shares from the underwriters at the public offering price under its previously announced share repurchase program, funded from cash on hand and its credit facility, though it has not committed to a minimum purchase. D.A. Davidson and Co. is acting as sole book-running manager.

The offering was made under a shelf registration filed on June 9, 2025, that became effective on June 18. Fosun agreed to a 90-day lockup. A subsequent regulatory filing showed that after the offering closed, Fosun Pharma beneficially owned 64,167 shares, or about 0.35 percent of the company, largely ending a stake it had held since 2014.